Trial Profile
A Study to Investigate the Absorption, Metabolism, Excretion, and Mass Balance of GC4419 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Nov 2017
Price :
$35
*
At a glance
- Drugs Avasopasem manganese (Primary)
- Indications Head and neck cancer; Stomatitis
- Focus Pharmacokinetics
- Sponsors Galera Therapeutics
- 15 Nov 2017 Status changed from not yet recruiting to completed.
- 24 May 2017 New trial record